Pregled bibliografske jedinice broj: 1272433
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting // European Journal of Surgical Oncology, 45 (2019), 1; 75-80 doi:10.1016/j.ejso.2018.01.078 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1272433 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Mesothelioma and thymic tumors: Treatment challenges
in (outside) a network setting
Autori
Imbimbo, Martina ; Maury, Jean-Michel ; Garassino, Marina ; Girard, Nicolas ; Hackl, Monika ; Eycken, Elizabeth Van ; Henau, Kris ; Dimitrova, Nadya ; Sekerija, Mario ; Dušek, Ladislav ; Mägi, Margit ; Malila, Nea ; Leinonen, Maarit ; Velten, Michel ; Troussard, Xavier ; Bouvier, Veronique ; Guizard, Anne-Valérie ; Bouvier, Anne-Marie ; Arveux, Patrick ; Maynadié, Marc ; Woronoff, Anne-Sophie ; Robaszkiewicz, Michel ; Baldi, Isabelle ; Monnereau, Alain ; Tretarre, Brigitte ; Colonna, Marc ; Molinié, Florence ; Bara, Simona ; Schvartz, Claire ; Lapôtre-Ledoux, Bénédicte ; Grosclaude, Pascale ; Stabenow, Roland ; Luttmann, Sabine ; Nennecke, Alice ; Engel, Jutta ; Schubert-Fritschle, Gabriele ; Heidrich, Jan ; Holleczek, Bernd ; Jónasson, Jón Gunnlaugur ; Clough-Gorr, Kerri ; Comber, Harry ; Mazzoleni, Guido ; Giacomin, Adriano ; Sardo, Antonella Sutera ; Barchielli, Alessandro ; Serraino, Diego ; De Angelis, Roberta ; Mallone, Sandra ; Tavilla, Andrea ; Pierannunzio, Daniela ; Rossi, Silvia ; Santaquilani, Mariano ; Knijn, Arnold ; Pannozzo, Fabio ; Gennaro, Valerio ; Benfatto, Lucia ; Ricci, Paolo ; Autelitano, Mariangela ; Spagnoli, Gianbattista ; Fusco, Mario ; Usala, Mario ; Vitale, Francesco ; Michiara, Maria ; Tumino, Rosario ; Mangone, Lucia ; Falcini, Fabio ; Ferretti, Stefano ; Angela Filiberti, Rosa ; Marani, Enza ; Iannelli, Arturo ; Sensi, Flavio ; Piffer, Silvano ; Gentilini, Maria ; Madeddu, Anselmo ; Ziino, Antonio ; Maspero, Sergio ; Candela, Pina ; Stracci, Fabrizio ; Tagliabue, Giovanna ; Rugge, Massimo ; Trama, Annalisa ; Gatta, Gemma ; Botta, Laura ; Capocaccia, Riccardo ; Pildava, Santa ; Smailyte, Giedre ; Calleja, Neville ; Johannesen, Tom Børge ; Rachtan, Jadwiga ; Góźdź, Stanisław ; Błaszczyk, Jerzy ; Kępska, Kamila ; de Lacerda, Gonçalo Forjaz ; Bento, Maria José ; Miranda, Ana ; Diba, Chakameh Safaei ; Almar, Enrique ; Larrañaga, Nerea ; de Munain, Arantza Lopez ; Torrella-Ramos, Ana ; Díaz García, José María ; Marcos-Gragera, Rafael ; Sanchez, Maria Josè ; Navarro, Carmen ; Salmeron, Diego ; Moreno-Iribas, Conchi ; Galceran, Jaume ; Carulla, Marià ; Mousavi, Mohsen ; Bouchardy, Christine ; Ess, Silvia M. ; Bordoni, Andrea ; Konzelmann, Isabelle ; Rashbass, Jem ; Gavin, Anna ; Brewster, David H. ; Huws, Dyfed Wyn ; Visser, Otto ; Bielska-Lasota, Magdalena ; Primic-Zakelj, Maja ; Kunkler, Ian ; Benhamou, Ellen
Kolaboracija
RARECARENet Working Group
Izvornik
European Journal of Surgical Oncology (0748-7983) 45
(2019), 1;
75-80
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
mesothelioma, thymic tumours, clinical trials
Sažetak
The management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of databases, translational research programs, and clinical trials. Access to innovative strategies represents a major challenge, as there is a lack of funding for clinical research in rare cancers and their rarity precludes the design of robust clinical trials that could lead to specific approval of drugs. In this context, patient-centered initiatives, such as the establishment of dedicated networks, are warranted. International societies, such as IMIG (International Mesothelioma Interest Group) and ITMIG (International Thymic Malignancy Interest Group) provide infrastructure for global collaboration, and there are many advantages to having strong regional groups working on the same issues. There may be regional differences in risk factors, susceptibility, management and outcomes. The ability to address questions both regionally as well as globally is ideal to develop a full understanding of mesothelioma and thymic malignancies. In Europe, through the integration of national networks with EURACAN, the collaboration with academic societies and international groups, the development of networks in thoracic oncology provides multiplex integration of clinical care and research, ultimately ensuring equal access to high quality care to all patients, with the opportunity of conducting high level clinical and translational research projects.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Hrvatski zavod za javno zdravstvo,
Medicinski fakultet, Zagreb
Profili:
Mario Šekerija
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE